US 11814428
Anti-PTCRA antibody-drug conjugates and uses thereof
granted A61KA61K47/68031A61K47/68033
Quick answer
US patent 11814428 (Anti-PTCRA antibody-drug conjugates and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K47/68031, A61K47/68033, A61K47/6849, A61K47/6897